Dexcom (DXCM) FY2013 results: revenue $160 million, up 60.2% on the year
Dexcom Inc. (DXCM) reported revenue of $160 million for fiscal 2013, the year ended 31 December 2013, up 60.2% on the year before. Net income was -$30 million, and diluted earnings per share $-0.42. The figures are the company's own, from the 10-K it filed with the SEC on 20 February 2014.
Revenue
$160 million
+60.2% on the year
FY2009FY2013
Operating margin
-18.1%
-55.8% a year earlier
FY2009FY2013
Net income
-$30 million
FY2009FY2013
Diluted EPS
-$0.42
FY2009FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
160
99.9
76.3
+60.2%
Cost of revenue
59.9
53.3
40.4
+12.4%
Gross profit
100
46.6
35.8
+114.8%
Gross margin
62.6%
46.6%
47.0%
Research and development
44.8
38.3
29.6
+17.0%
Selling, general and administrative
84.2
64.0
51.1
+31.6%
Operating income
-28.9
-55.7
-44.8
Operating margin
-18.1%
-55.8%
-58.8%
Interest expense
0.9
0.2
0.0
+350.0%
Pre-tax income
-29.8
-55.8
-44.7
Income tax
0.0
-1.3
0.0
Net income
-29.8
-54.5
-44.7
Net margin
-18.6%
-54.6%
-58.7%
Diluted EPS
-$0.42
-$0.79
-$0.68
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
2.4
-33.1
-30.1
Capital expenditure
7.9
9.5
8.0
-16.8%
Free cash flow
-5.5
-42.6
-38.1
Free cash flow margin
-3.4%
-42.6%
-50.0%
Cash from investing
20.9
28.4
-46.4
-26.4%
Cash from financing
11.8
10.2
74.2
+15.7%
Depreciation and amortisation
7.0
6.6
3.8
+6.1%
Share-based compensation
24.6
18.4
13.5
+33.7%
Shares outstanding at period end
72m
70m
68m
+4.3%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
84.1
77.0
104
+9.2%
Debt
6.8
7.0
0.0
-2.9%
Other liabilities
31.6
22.0
16.0
+43.6%
Total liabilities and equity
122
106
120
+15.6%
Fixed assets
20.7
18.9
15.0
+9.5%
Goodwill
3.2
3.2
0.0
0.0%
Intangible assets
3.6
4.2
0.0
-14.3%
Investments
11.4
40.6
79.4
-71.9%
Cash and equivalents
43.2
8.1
2.6
+433.3%
Inventory
9.0
7.4
8.2
+21.6%
Other assets
31.4
23.6
15.3
+33.1%
Total assets
122
106
120
+15.6%
10-K for the year ended 31 December 2013, filed 20 February 2014: the filing.